These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 563741)

  • 21. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
    Villégier AS; Drouin C; Bizot JC; Marien M; Glowinski J; Colpaërt F; Tassin JP
    Synapse; 2003 Dec; 50(4):277-84. PubMed ID: 14556232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Respective effects on locomotor activity of injections of 5, 7-DHT in median raphe nucleus and of 6-OHDA in the mesolimbic dopaminergic group area in the rat].
    Galey D; LeMoal M
    C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(1):65-8. PubMed ID: 402230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-Amphetamine potentiates muscimol-induced disinhibition of A10 dopaminergic neurons in the rat.
    Overton PG; Lokwan SJ; Berry MS; Clark D
    J Neural Transm (Vienna); 2000; 107(12):1381-91. PubMed ID: 11458991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat.
    Kelley AE; Stinus L; Iversen SD
    Behav Brain Res; 1980 Feb; 1(1):3-24. PubMed ID: 6269560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area.
    Kamata K; Rebec GV
    Life Sci; 1984 Jun; 34(24):2419-27. PubMed ID: 6727576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of lesions in the A10 dopaminergic area of the rat.
    Galey D; Simon H; Le Moal M
    Brain Res; 1977 Mar; 124(1):83-97. PubMed ID: 300268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and responses to amphetamine in rats.
    Sessions GR; Meyerhoff JL; Kant GJ; Koob GF
    Pharmacol Biochem Behav; 1980 Apr; 12(4):603-8. PubMed ID: 7393956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats.
    Geyer MA; Russo PV; Segal DS; Kuczenski R
    Pharmacol Biochem Behav; 1987 Nov; 28(3):393-9. PubMed ID: 3685075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does tolerance develop to low doses of d- and l-amphetamine on locomotor activity in rats?
    Weston PF; Overstreet DH
    Pharmacol Biochem Behav; 1976 Dec; 5(6):645-9. PubMed ID: 1023233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of continuous systemic infusion of D-amphetamine on the sensitivity of nigral dopamine cells to apomorphine inhibition of firing rates.
    Ellinwood EH; Lee TH
    Brain Res; 1983 Aug; 273(2):379-83. PubMed ID: 6616245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearance of hoarding and disorganization of eating behavior after ventral mesencephalic tegmentum lesions in rats.
    Stinus L; Gaffori O; Simon H; Le Moal M
    J Comp Physiol Psychol; 1978 Apr; 92(2):289-96. PubMed ID: 670455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity.
    Diana M; Muntoni AL; Pistis M; Collu M; Forgione A; Gessa GL
    Eur J Pharmacol; 1996 Sep; 312(2):179-81. PubMed ID: 8894593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro.
    Seutin V; Verbanck P; Massotte L; Dresse A
    Brain Res; 1991 Aug; 558(1):141-4. PubMed ID: 1933376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-deoxy-D-(14C)-glucose study of the interaction of caerulein and apomorphine.
    Sugaya K; Maimets MO; Kubota K
    Jpn J Pharmacol; 1988 Sep; 48(1):131-6. PubMed ID: 3199600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopamine agonists and antagonists in Tourette's disease.
    Feinberg M; Carroll BJ
    Arch Gen Psychiatry; 1979 Aug; 36(9):979-85. PubMed ID: 380492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic agonists differentially affect open-field activity of rats with A10 lesions.
    Hodge GK; Boyeson MG; Linn RT
    Psychopharmacology (Berl); 1981; 73(1):39-42. PubMed ID: 6785788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses.
    Lerer B; Globus M; Brik E; Hamburger R; Belmaker RH
    Neuropsychobiology; 1984; 11(1):28-32. PubMed ID: 6738831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventral mesencephalic tegmentum (VMT) controls electrocortical beta rhythms and associated attentive behaviour in the cat.
    Montaron MF; Bouyer JJ; Rougeul A; Buser P
    Behav Brain Res; 1982 Oct; 6(2):129-45. PubMed ID: 6814463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic D-amphetamine induces sexually dimorphic effects on locomotion, recognition memory, and brain monoamines.
    Bisagno V; Ferguson D; Luine VN
    Pharmacol Biochem Behav; 2003 Mar; 74(4):859-67. PubMed ID: 12667900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.